[1]
|
王亚楠, 吴思缈, 刘鸣. 中国脑卒中15年变化趋势和特点[J]. 华西医学, 2021, 36(6): 803-807.
|
[2]
|
《中国脑卒中防治报告》编写组. 《中国脑卒中防治报告2019》概要[J]. 中国脑血管病杂志, 2020, 17(5): 272-281.
|
[3]
|
张培培, 张祥建, 高硕君. 肠道菌群失调可增加脑卒中风险[J]. 中华神经科杂志, 2017, 50(10): 781-785.
|
[4]
|
刘伟, 方黎, 江选东, 李中秋. 老年急性脑梗死合并代谢综合征患者的认知损伤表现分析[J]. 中国实用神经疾病杂志, 2014, 17(22): 26-27, 28.
|
[5]
|
石强. 脑梗死合并代谢综合征的临床特征及预后分析[J]. 实用临床医药杂志, 2015, 19(15): 14-17.
|
[6]
|
Mazidi, M., Rezaie, P., Kengne, A.P., Mobarhan, M.G. and Ferns, G.A. (2016) Gut Microbiome and Metabolic Syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 10, S150-S157.
https://doi.org/10.1016/j.dsx.2016.01.024
|
[7]
|
Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V.D., Sokol, H, Doré, J., et al. (2009) The Firmicutes/Bacteroidetes Ratio of the Human Microbiota Changes with Age. BMC Microbiology, 9, Article No. 123.
https://doi.org/10.1186/1471-2180-9-123
|
[8]
|
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva Datchary, P., et al. (2015) Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host & Microbe, 17, 690-703.
https://doi.org/10.1016/j.chom.2015.04.004
|
[9]
|
Winek, K., Meisel, A. and Dirnagl, U. (2016) Gut Microbiota Impact on Stroke Outcome: Fad or Fact? Journal of Cerebral Blood Flow & Metabolism, 36, 891-898. https://doi.org/10.1177%2F0271678X16636890
|
[10]
|
Tan, B.Y.Q., Paliwal, P.R. and Sharma, V.K. (2020) Gut Microbiota and Stroke. Annals of Indian Academy of Neurology, 23, 155-158.
|
[11]
|
Kazlauskienė, L., Butnorienė, J. and Norkus, A. (2015) Metabolic Syndrome Related to Cardiovascular Events in a 10-Year Prospective Study. Diabetology & Metabolic Syndrome, 7, Article No. 102.
https://doi.org/10.1186/s13098-015-0096-2
|
[12]
|
Fang, X., Liu, H., Zhang, X., Zhang, H., Qin, X. and Ji, X. (2016) Metabolic Syndrome, Its Components, and Diabetes on 5-Year Risk of Recurrent Stroke among Mild-to-Moderate Ischemic Stroke Survivors: A Multiclinic Registry Study. Journal of Stroke and Cerebrovascular Diseases, 25, 626-634.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.11.017
|
[13]
|
Zuo, H.J., Xie, Z.M., Zhang, W.W., Li, Y.-R., Wang, W., Ding, X.-B., et al. (2011) Gut Bacteria Alteration in Obese People and Its Relationship with Gene Polymorphism. World Journal of Gastroenterology, 17, 1076-1081.
|
[14]
|
Tseng, C.H. and Wu, C.Y. (2019) The Gut Microbiome in Obesity. Journal of the Formosan Medical Association, 118, S3-S9. https://doi.org/10.1016/j.jfma.2018.07.009
|
[15]
|
Lee, C.J., Sears, C.L. and Maruthur, N. (2020) Gut Microbiome and Its Role in Obesity and Insulin Resistance. Annals of the New York Academy of Sciences, 1461, 37-52. https://doi.org/10.1111/nyas.14107
|
[16]
|
Li, X., Liu, L., Cao, Z., Li, W., Li, H., Lu, C., et al. (2020) Gut Microbiota as an “Invisible Organ” That Modulates the Function of Drugs. Biomedicine & Pharmacotherapy, 121, Article ID: 109653.
https://doi.org/10.1016/j.biopha.2019.109653
|
[17]
|
Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. (2007) Metabolic Endotoxemia Initiates Obesity and Insulin Resistance. Diabetes, 56, 1761-1772. https://doi.org/10.2337/db06-1491
|
[18]
|
Li, J., Zhang, H. and Wang, G. (2020) Correlations between Inflammatory Response, Oxidative Stress, Intestinal Pathological Damage and Intestinal Flora Variation in Rats with Type 2 Diabetes Mellitus. European Review for Medical and Pharmacological Sciences, 24, 10163-10168.
|
[19]
|
Silva, Y.P., Bernardi, A. and Frozza, R.L. (2020) The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in Endocrinology, 11, Article No. 25. https://doi.org/10.3389/fendo.2020.00025
|
[20]
|
Zhu, W., Gregory, J.C., Org, E., Buffa, J.A., Gupta, N., Wang, Z., et al. (2016) Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell, 165, 111-124. https://doi.org/10.1016/j.cell.2016.02.011
|
[21]
|
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., et al. (2012) A Metagenome-Wide Association Study of gut Microbiota in Type 2 Diabetes. Nature, 490, 55-60. https://doi.org/10.1038/nature11450
|
[22]
|
陈诚, 陆明, 夏娟, 陈琳, 雷涛. 肠道菌群与2型糖尿病关系的研究进展[J]. 医学综述, 2017, 23(15): 3072-3076.
|
[23]
|
Canfora, E.E., Meex, R.C.R., Venema, K. and Blaak, E.E. (2019) Gut Microbial Metabolites in Obesity, NAFLD and T2DM. Nature Reviews. Endocrinology, 15, 261-273. https://doi.org/10.1038/s41574-019-0156-z
|
[24]
|
Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C.J., Fagerberg, B., et al. (2013) Gut Metagenome in European Women with Normal, Impaired and Diabetic Glucose Control. Nature, 498, 99-103.
https://doi.org/10.1038/nature12198
|
[25]
|
Ma, Q., Li, Y., Li, P., Wang, M., Tang, Z., Wang, T., et al. (2019) Research Progress in the Relationship between Type 2 Diabetes Mellitus and Intestinal Flora. Biomedicine & Pharmacotherapy, 117, Article ID: 109138.
https://doi.org/10.1016/j.biopha.2019.109138
|
[26]
|
Honour, J. (1982) The Possible Involvement of Intestinal Bacteria in Steroidal Hypertension. Endocrinology, 110, 285-287. https://doi.org/10.1210/endo-110-1-285
|
[27]
|
Yang, T., Santisteban, M.M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J.M., et al. (2015) Gut Dysbiosis Is Linked to Hypertension. Hypertension, 65, 1331-1340. https://doi.org/10.1161/HYPERTENSIONAHA.115.05315
|
[28]
|
Li, J., Zhao, F., Wang, Y., Chen, J., Tao, J., Tian, G., et al. (2017) Gut Microbiota Dysbiosis Contributes to the Development of Hypertension. Microbiome, 5, Article No. 14. https://doi.org/10.1186/s40168-016-0222-x
|
[29]
|
Jose, P.A. and Raj, D. (2015) Gut Microbiota in Hypertension. Current Opinion in Nephrology and Hypertension, 24, 403-409. https://doi.org/10.1097/MNH.0000000000000149
|
[30]
|
Li, J., Yang, X., Zhou, X. and Cai, J. (2021) The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development. Antioxidants & Redox Signaling, 34, 811-830. https://doi.org/10.1089/ars.2020.8104
|
[31]
|
Wilck, N., Matus, M.G., Kearney, S.M., Olesen, S.W., Forslund, K., Bartolomaeus, H., et al. (2017) Salt-Responsive Gut Commensal Modulates TH17 Axis and Disease. Nature, 551, 585-589. https://doi.org/10.1038/nature24628
|
[32]
|
Wang, J., Kuo, C.-H., Kuo, F.-C., Wang, Y.-K., Hsu, W.-H., Yu, F.-J., et al. (2019) Fecal Microbiota Transplantation: Review and Update. Journal of the Formosan Medical Association, 118, S23-S31.
https://doi.org/10.1016/j.jfma.2018.08.011
|
[33]
|
Adak, A. and Khan, M.R. (2019) An Insight into Gut Microbiota and Its Functionalities. Cellular and Molecular Life Sciences, 76, 473-493. https://doi.org/10.1007/s00018-018-2943-4
|
[34]
|
Smits, L.P., Kootte, R.S., Levin, E., Prodan, A., Fuentes, S., Zoetendal, E.G., et al. (2018) Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients with Metabolic Syndrome. Journal of the American Heart Association, 7, Article No. e008342.
https://doi.org/10.1161/JAHA.117.008342
|
[35]
|
Torres-Fuentes, C., Schellekens, H., Dinan, T.G. and Cryan, J.F. (2017) The Microbiota-Gut-Brain Axis in Obesity. Lancet Gastroenterology & Hepatology, 2, 747-756. https://doi.org/10.1016/S2468-1253(17)30147-4
|